Kinetics of p53 binding to promoter sites in vivo

Molecular and Cellular Biology

Volumn 21, Issue 10, 2001, Pages 3375-3386

  Szak, S T ^a   Mays, D ^a   Pietenpol, J A ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PROTEIN MDM2; PROTEIN P21; PROTEIN P35;

ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER INHIBITION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; IONIZING RADIATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; KINETICS; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED;

EID: 0035028599     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.10.3375-3386.2001     Document Type: Article

References (43)

1. Regulation of p53 function and stability by phosphorylation
2. Recruitment of p300/CBP in p53-dependent signal pathways
3. Enhanced phosphorylation of p53 by ATM in response to DNA damage
4. mdm2 expression is induced by wild type p53 activity
5. c-Myc target gene specificity is determined by a post-DNA-binding mechanism
6. Retinoblastoma protein recruits histone deacetylase to repress transcription
7. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
8. CIPI/WAF1 undergo normal development, but are defective in G1 checkpoint control
9. 1 arrest and apoptosis
10. WAF1, a potential mediator of p53 tumor suppression
11. 2 checkpoint is retinoblastoma protein dependent
12. p53 phosphorylation mutants retain transcription activity
13. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
14. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
15. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclindependent kinases
16. Cell type-specific inhibition of p53-mediated apoptosis by mdm2
17. Mdm2 promotes the rapid degradation of p53
18. The emerging p53 gene family
19. Regulation of p53 stability by Mdm2
20. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage
21. Retinoblasroma protein represses transcription by recruiting a histone deacetylase
22. 2 terminus of p53 facilitates transactivation
23. Mechanisms of switching on p53: A role for covalent modification?
24. Tumor suppressor p53 is a direct transcriptional activator of the human bar gene
25. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a
26. p53AlP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser46-phosphorylated p53
27. A model for p53-induced apoptosis
28. DNA damage activates p53 through a phosphorylation-acetylation cascade
29. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor α
30. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization
31. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
32. Waf1/Cip1 inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption
33. High affinity insertion/deletion lesion binding by p53 - Evidence for a role of the p53 central domain
34. Critical role for Set20 of human p53 in the negative regulation of p53 by Mdm2
35. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity
36. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression
37. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases
38. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins
39. Target gene specificity of E2F and pocket protein family members in living cells
40. The p53-mdm-2 autoregulatory feedback loop
41. p21 is a universal inhibitor of cyclin kinases
42. A functional p53-responsive intronic promoter is contained within the human mdm2 gene
43. Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function